Publicacions en col·laboració amb investigadors/es de Hospital Virgen de la Arrixaca (157)

2024

  1. Detection of inflammasome activation in liver tissue during the donation process as potential biomarker for liver transplantation

    Cell Death Discovery, Vol. 10, Núm. 1

  2. GEMA-Na and MELD 3.0 severity scores to address sex disparities for accessing liver transplantation: a nationwide retrospective cohort study

    eClinicalMedicine, Vol. 74

  3. Operational tolerance research in liver transplantation: a bibliometric analysis using a new web resource

    Frontiers in Research Metrics and Analytics, Vol. 9

  4. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

    Liver International, Vol. 44, Núm. 1, pp. 250-262

2023

  1. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years

    GeroScience, Vol. 45, Núm. 1, pp. 543-553

  2. Effectiveness and safety of once-daily tacrolimus formulations in de novo liver transplant recipients: The PRETHI study

    Clinical Transplantation, Vol. 37, Núm. 12

  3. Endothelial cell activation mediated by cold ischemia-released mitochondria is partially inhibited by defibrotide and impacts on early allograft function following liver transplantation

    Biomedicine and Pharmacotherapy, Vol. 167

  4. Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles?

    Biomedicines, Vol. 11, Núm. 9

  5. Postoperative negative-pressure incision therapy after liver transplant (PONILITRANS study): A randomized controlled trial

    Surgery (United States), Vol. 173, Núm. 4, pp. 1072-1078

  6. Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis

    Cancers, Vol. 15, Núm. 7

2022

  1. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  2. Emerging Role of NLRP3 Inflammasome and Pyroptosis in Liver Transplantation

    International Journal of Molecular Sciences, Vol. 23, Núm. 22

  3. Pancreatic encephalopathy, a little known complication of acute pancreatitis

    Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva, Vol. 114, Núm. 2, pp. 122-123

2021

  1. A high concentration of TGF-β correlates with opportunistic infection in liver and kidney transplantation

    Human Immunology, Vol. 82, Núm. 6, pp. 414-421

  2. Are We Ready for Bariatric Surgery in a Liver Transplant Program? A Meta-Analysis

    Obesity Surgery, Vol. 31, Núm. 3, pp. 1214-1222

  3. Biomarkers of Early Liver Graft Damage in Circulatory Death and Brain Death Donors: A Propensity Score Matching Analysis

    Transplantation Proceedings, Vol. 53, Núm. 9, pp. 2659-2662

  4. Changes in humoral immune response after SARS-CoV-2 infection in liver transplant recipients compared to immunocompetent patients

    American Journal of Transplantation, Vol. 21, Núm. 8, pp. 2876-2884

  5. Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 148-155

  6. Identification of peripheral CD154+ T cells and HLA-DRB1 as biomarkers of acute cellular rejection in adult liver transplant recipients

    Clinical and Experimental Immunology, Vol. 203, Núm. 2, pp. 315-328

  7. Modulating immunosuppression in liver transplant patients with COVID-19

    Gut